Zhejiang Cheng Yi Pharmaceutical Co., Ltd. (SHA:603811)
China · Delayed Price · Currency is CNY 10.16
-0.29 (-2.78%)
Jun 11, 2026, 2:14 PM CST
SHA:603811 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 10, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 3,320 | 3,336 | 2,527 | 3,394 | 3,271 | 3,794 | |
Market Cap Growth | 14.74% | 32.01% | -25.55% | 3.77% | -13.80% | -1.64% |
Enterprise Value | 3,114 | 3,254 | 2,635 | 3,600 | 3,489 | 3,857 |
Last Close Price | 10.45 | 10.50 | 7.51 | 9.80 | 9.31 | 10.60 |
PE Ratio | 17.12 | 17.10 | 12.59 | 20.84 | 20.24 | 22.22 |
PS Ratio | 4.01 | 4.11 | 3.54 | 5.05 | 4.99 | 5.47 |
PB Ratio | 2.28 | 2.39 | 2.00 | 2.84 | 3.00 | 3.80 |
P/TBV Ratio | 2.37 | 2.49 | 2.11 | 3.02 | 3.21 | 4.15 |
P/FCF Ratio | 15.14 | 14.20 | 17.33 | 27.39 | - | 404.58 |
P/OCF Ratio | 11.89 | 11.90 | 12.28 | 17.43 | 19.71 | 26.44 |
EV/Sales Ratio | 3.76 | 4.01 | 3.69 | 5.36 | 5.33 | 5.56 |
EV/EBITDA Ratio | 11.81 | 12.18 | 12.06 | 18.18 | 19.73 | 18.50 |
EV/EBIT Ratio | 18.35 | 18.81 | 21.35 | 29.83 | 30.25 | 25.08 |
EV/FCF Ratio | 14.20 | 13.85 | 18.07 | 29.05 | - | 411.29 |
Debt / Equity Ratio | 0.04 | 0.03 | 0.18 | 0.37 | 0.39 | 0.15 |
Debt / EBITDA Ratio | 0.21 | 0.14 | 1.05 | 2.23 | 2.40 | 0.71 |
Debt / FCF Ratio | 0.25 | 0.16 | 1.58 | 3.58 | - | 15.84 |
Net Debt / Equity Ratio | -0.15 | -0.13 | 0.05 | 0.13 | 0.20 | 0.07 |
Net Debt / EBITDA Ratio | -0.81 | -0.68 | 0.27 | 0.76 | 1.21 | 0.31 |
Net Debt / FCF Ratio | -0.97 | -0.78 | 0.40 | 1.21 | -2.45 | 6.95 |
Asset Turnover | 0.48 | 0.47 | 0.40 | 0.37 | 0.43 | 0.55 |
Inventory Turnover | 2.19 | 2.05 | 1.81 | 2.18 | 1.91 | 1.77 |
Quick Ratio | 1.24 | 0.98 | 0.87 | 1.14 | 1.18 | 0.66 |
Current Ratio | 1.75 | 1.49 | 1.35 | 1.51 | 1.69 | 1.17 |
Return on Equity (ROE) | 14.13% | 14.83% | 16.31% | 14.17% | 15.43% | 18.17% |
Return on Assets (ROA) | 6.13% | 6.30% | 4.26% | 4.18% | 4.74% | 7.60% |
Return on Invested Capital (ROIC) | 12.20% | 12.03% | 8.51% | 8.48% | 9.58% | 13.34% |
Return on Capital Employed (ROCE) | 11.20% | 12.00% | 8.60% | 7.80% | 7.90% | 14.30% |
Earnings Yield | 5.83% | 5.85% | 7.94% | 4.80% | 4.94% | 4.50% |
FCF Yield | 6.61% | 7.04% | 5.77% | 3.65% | -2.66% | 0.25% |
Dividend Yield | 2.86% | 2.86% | 3.33% | 2.04% | 1.92% | 1.68% |
Payout Ratio | 42.54% | 42.78% | 38.21% | 45.40% | 42.57% | 36.81% |
Buyback Yield / Dilution | 3.62% | 2.78% | -0.99% | 1.20% | -0.67% | -0.59% |
Total Shareholder Return | 6.48% | 5.64% | 2.34% | 3.24% | 1.25% | 1.10% |